Ginsenoside Rg1 and astaxanthin act on the hypothalamus to protect female mice against reproductive aging
Female infertility linked to reproductive aging is a growing concern worldwide, with more women facing challenges conceiving later in life. Research shows oxidative stress—damage from unstable molecules called free radicals—plays a major role in this decline. While the hypothalamic-pituitary-ovarian (HPO) axis (the brain-ovary system controlling fertility) changes with age, new research highlights the hypothalamus (a small brain region) as a key early player in reproductive aging.
Scientists from Fujian Medical University in China set out to test whether two natural antioxidants—ginsenoside Rg1 (a bioactive compound in ginseng) and astaxanthin (a red carotenoid found in salmon, shrimp, and algae)—could protect the hypothalamus and preserve fertility in aging female mice. Their findings, published in the Chinese Medical Journal in 2022, offer promising clues about how natural compounds might delay reproductive decline.
The team studied two groups of mice: young (3–4 months old, with regular 4–5 day “estrous cycles,” the mouse equivalent of a menstrual cycle) and middle-aged (9–10 months old, with irregular cycles lasting over 6 days—an early sign of reproductive aging). They monitored cycles daily using vaginal smears, a standard way to track fertility in mice.
To test the antioxidants, they selected 80 young mice with regular cycles and split them into four groups: saline (control), Rg1, olive oil (control), and astaxanthin. They gave Rg1 (6 mg per kg of body weight) or astaxanthin (2 mg per kg) via belly injections every three days for six months—starting at 3 months old (when brain cells called astrocytes first show signs of aging) and continuing until the mice were 9–10 months old. They tracked cycle regularity at 6, 10, and 12 months.
The results were clear: as mice aged, fewer in the control groups had regular cycles. But mice treated with Rg1 or astaxanthin were far more likely to keep regular cycles at 6 and 10 months. By 12 months, differences faded—showing the antioxidants delay, but do not stop, aging.
The real breakthrough was how the antioxidants worked. The hypothalamus of middle-aged mice had more “senescent” (old, damaged) astrocytes—cells that support brain function. These cells showed high levels of oxidative damage (measured by peroxidase activity) and a “senescence associated secretory phenotype (SASP)”—a state where old cells release pro-inflammatory molecules (like IL-1β, IL-6, and TNF-α) that harm nearby tissue.
Rg1 and astaxanthin cut this damage:
- They lowered levels of senescence markers (p16 and p21 genes), which are linked to cell aging.
- They reduced the number of old astrocytes (stained with a blue dye called SA-β-Gal).
- They decreased harmful pro-inflammatory cytokines in the hypothalamus.
- They boosted activity of T-SOD, an enzyme that fights free radicals, and cut MDA, a waste product of cell damage—clear signs of reduced oxidative stress.
The antioxidants also helped the ovaries: they reduced senescence and inflammation there too. But the study’s biggest takeaway was their impact on the hypothalamus—something no previous antioxidant study had focused on.
These results suggest that long-term use of ginsenoside Rg1 and astaxanthin may help preserve fertility in aging females by protecting both the hypothalamus and ovaries from oxidative stress. While the study was in mice, it adds to growing evidence that natural antioxidants could play a role in managing reproductive aging. More research is needed to understand exactly how these compounds work in humans and to test safe doses.
This research was published by Xiaoman Dai, Guirong Zeng, Luyan Hong, Qinyong Ye, Xiaochun Chen, and Jing Zhang from the Department of Neurology and Geriatrics at Fujian Institute of Geriatrics and Fujian Key Laboratory of Molecular Neurology in the Chinese Medical Journal (2022, Volume 135, Issue 1). The full study is available at doi.org/10.1097/CM9.0000000000001542
Was this helpful?
0 / 0